Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.

about

Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.

Item

http://www.wikidata.org/entity/Q45911250

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@en

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@nl

type

Item

label

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@en

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@nl

prefLabel

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@en

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@nl

P1476

Escalating topotecan in combin ...... n advanced pediatric sarcomas.

@en

P2093

A Wawer

http://www.w3.org/2001/XMLSchema#string

B Filipiak-Pittroff

http://www.w3.org/2001/XMLSchema#string

F Bauer

http://www.w3.org/2001/XMLSchema#string

I von Luettichau

http://www.w3.org/2001/XMLSchema#string

S Burdach

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.

Update on the role of topotecan in the treatment of recurrent ovarian cancer.

Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.

Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial.

Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial.

Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.

New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors.

P304

263-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08880018.2013.777948

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23509879

http://www.w3.org/2001/XMLSchema#string